Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

COVID-19 doesn't make alopecia areata worse.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

PRP treatment may help with alopecia areata, especially in newer cases.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.